{"id":549,"date":"2020-09-26T12:03:09","date_gmt":"2020-09-26T12:03:09","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=549"},"modified":"2020-09-26T12:04:18","modified_gmt":"2020-09-26T12:04:18","slug":"23-sep-2020-tinospora-cordifolia-proven-to-be-effective-in-asymptomatic-patients","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/23-sep-2020-tinospora-cordifolia-proven-to-be-effective-in-asymptomatic-patients\/","title":{"rendered":"(23 Sep 2020) Tinospora Cordifolia- proven to be effective in asymptomatic patients"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p id=\"page-title\" class=\"highwire-cite-title\">Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 infection: An Open Label Feasibility Study<\/p>\n<p>https:\/\/www.medrxiv.org\/content\/10.1101\/2020.09.20.20198515v1<\/p>\n<p class=\"\">An open label, feasibility trial (<a class=\"external-ref external-ref-type-clintrialgov\" href=\"https:\/\/www.medrxiv.org\/lookup\/external-ref?link_type=CLINTRIALGOV&amp;access_num=NCT04542876&amp;atom=%2Fmedrxiv%2Fearly%2F2020%2F09%2F23%2F2020.09.20.20198515.atom\">NCT04542876<\/a>)was conducted on 46 patients in the hospital setting. A single-arm study with no control group and blinding was executed in Jodhpur, Rajasthan, India. All patients orally received 2 tablets (1000 mg) twice daily for 2 weeks. Clinical parameters were collected at baseline, day 3, day 7 and day 14. Patients were continuously monitored for side effects and adverse reactions during the study period. Out of 46 asymptomatic patients included in the study, 40 completed the 14-day follow-up period. None developed any Covid-19 symptoms after admission to the hospital. On day 3 post-treatment, viral clearance was reported in 16 (32.5%) patients. By the end of D-7, 38 (95%) patients had viral load disappearance. Follow-up at D-14 showed that all participants tested negative. In adult patients with asymptomatic Covid-19, Gudhuchi Ghan Vati could be effective. Randomized controlled trials with larger sample sizes in patients with Covid-19 are urgently needed to confirm the definite benefit with Ayurveda.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 infection: An Open Label Feasibility Study https:\/\/www.medrxiv.org\/content\/10.1101\/2020.09.20.20198515v1 An open label, feasibility trial (NCT04542876)was conducted on 46 patients in the hospital setting. A single-arm study with no control&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/23-sep-2020-tinospora-cordifolia-proven-to-be-effective-in-asymptomatic-patients\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(23 Sep 2020) Tinospora Cordifolia- proven to be effective in asymptomatic patients&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,76],"tags":[77],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/549"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=549"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/549\/revisions"}],"predecessor-version":[{"id":550,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/549\/revisions\/550"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}